These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22850530)

  • 21. [Modulation of the incretin effect in the treatment of diabetes].
    Vidal J
    Med Clin (Barc); 2014 Sep; 143 Suppl 2():8-11. PubMed ID: 25437459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incretin-based therapies and cardiovascular risk.
    Mannucci E; Dicembrini I
    Curr Med Res Opin; 2012 May; 28(5):715-21. PubMed ID: 22439700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.
    Avogaro A; Fadini GP
    Diabetes Care; 2014 Oct; 37(10):2884-94. PubMed ID: 25249673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipeptidyl peptidase-4 and GLP-1 interplay in STC-1 and GLUTag cell lines.
    Kamakura R; Raza GS; Prasannan A; Walkowiak J; Herzig KH
    Peptides; 2020 Dec; 134():170419. PubMed ID: 32998057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
    Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
    Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation.
    Wagner L; Kaestner F; Wolf R; Stiller H; Heiser U; Manhart S; Hoffmann T; Rahfeld JU; Demuth HU; Rothermundt M; von Hörsten S
    Neuropeptides; 2016 Jun; 57():21-34. PubMed ID: 26988064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incretin-based therapy and type 2 diabetes.
    Hare KJ; Knop FK
    Vitam Horm; 2010; 84():389-413. PubMed ID: 21094909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.
    Al-Aissa Z; Rosta K; Hadarits O; Harreiter J; Zóka A; Bancher-Todesca D; Patócs A; Kiss K; Sármán B; Pusztai P; Sziller I; Rigó J; Rácz K; Somogyi A; Kautzky-Willer A; Firneisz G
    Eur J Clin Invest; 2015 Feb; 45(2):196-203. PubMed ID: 25556541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):463-74. PubMed ID: 20852989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence.
    Pala L; Rotella CM
    J Diabetes Res; 2013; 2013():590456. PubMed ID: 23853775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Melo FJ; Pinto-Lopes P; Estevinho MM; Magro F
    Inflamm Bowel Dis; 2021 Jun; 27(7):1153-1165. PubMed ID: 33295607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Prostanoids Profile and Counter-Regulation of SDF-1α/CXCR4 and VIP/VPAC2 Expression by Sitagliptin in Non-Diabetic Rat Model of Hepatic Ischemia-Reperfusion Injury.
    Krzystek-Korpacka M; Fleszar MG; Fortuna P; Gostomska-Pampuch K; Lewandowski Ł; Piasecki T; Kosyk B; Szeląg A; Trocha M
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide 1 and cardiac cell survival.
    Ravassa S; Zudaire A; Díez J
    Endocrinol Nutr; 2012 Nov; 59(9):561-9. PubMed ID: 23031433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease.
    Remm F; Franz WM; Brenner C
    Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):185-93. PubMed ID: 27533760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of Dipeptidyl peptidase inhibitors in lung ischemia-reperfusion injury].
    Lu ZL; Gao ML; Deng Y; Liu BH; Li N; Geng Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1266-1270. PubMed ID: 36480859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on the Mechanism of Interaction between Dipeptidyl Peptidase 4 and Inhibitory Peptides Based on Gaussian Accelerated Molecular Dynamic Simulation.
    Liu Y; Zhao W; Jiang Y; Xing S; Li W
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
    Yazbeck R; Jaenisch SE; Abbott CA
    Biochem Pharmacol; 2021 Jun; 188():114517. PubMed ID: 33722535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):197-207. PubMed ID: 21748358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.
    Zhong J; Maiseyeu A; Davis SN; Rajagopalan S
    Circ Res; 2015 Apr; 116(8):1491-504. PubMed ID: 25858071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.
    Mulvihill EE; Drucker DJ
    Endocr Rev; 2014 Dec; 35(6):992-1019. PubMed ID: 25216328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.